Yeomans Consulting Group Inc. Purchases Shares of 730 Axon Enterprise, Inc. (NASDAQ:AXON)

Yeomans Consulting Group Inc. acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 730 shares of the biotechnology company’s stock, valued at approximately $434,000.

Other institutional investors have also recently made changes to their positions in the company. Dimensional Fund Advisors LP grew its holdings in Axon Enterprise by 10.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 186,473 shares of the biotechnology company’s stock valued at $54,874,000 after buying an additional 17,905 shares in the last quarter. Canada Pension Plan Investment Board boosted its position in shares of Axon Enterprise by 81.0% during the second quarter. Canada Pension Plan Investment Board now owns 5,067 shares of the biotechnology company’s stock worth $1,491,000 after acquiring an additional 2,267 shares during the last quarter. AE Wealth Management LLC grew its stake in Axon Enterprise by 24.8% during the second quarter. AE Wealth Management LLC now owns 831 shares of the biotechnology company’s stock valued at $245,000 after acquiring an additional 165 shares in the last quarter. ProShare Advisors LLC increased its holdings in Axon Enterprise by 9.2% in the 2nd quarter. ProShare Advisors LLC now owns 9,798 shares of the biotechnology company’s stock valued at $2,883,000 after acquiring an additional 826 shares during the last quarter. Finally, Public Sector Pension Investment Board increased its holdings in Axon Enterprise by 79.5% in the 2nd quarter. Public Sector Pension Investment Board now owns 2,604 shares of the biotechnology company’s stock valued at $766,000 after acquiring an additional 1,153 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on AXON. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Finally, Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $504.92.

Insiders Place Their Bets

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the transaction, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock valued at $30,721,337 over the last 90 days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

AXON stock opened at $613.38 on Friday. The stock has a market cap of $46.77 billion, a PE ratio of 158.50, a P/E/G ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67. The company has a 50-day moving average price of $617.43 and a 200 day moving average price of $467.42. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.